VNX-101-2

N/A

Report date: 2025/04/16 16:18:07

Base Information

Drug NameVNX-101-2
Drug Alias NameVNX-101-2
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAutoimmune DiseasesLupus Erythematosus, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVironexis Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesVironexis Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesLupus Erythematosus, Systemic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A